Mumbai, Nov. 14 -- Zydus Lifesciences announced that the USFDA conducted an inspection at LiqMeds, UK. The inspection was conducted from 9 to 13 November, 2026 and concluded with 4 observations. The Company will closely

work with the USFDA to address the observations expeditiously.

Published by HT Digital Content Services with permission from Capital Market....